Cyclin F-Mediated Degradation of Ribonucleotide Reductase M2 Controls Genome Integrity and DNA Repair

被引:309
|
作者
D'Angiolella, Vincenzo [1 ]
Donato, Valerio [1 ]
Forrester, Frances M. [1 ]
Jeong, Yeon-Tae [1 ]
Pellacani, Claudia [1 ]
Kudo, Yasusei [1 ,2 ]
Saraf, Anita [3 ]
Florens, Laurence [3 ]
Washburn, Michael P. [3 ,4 ]
Pagano, Michele [1 ,5 ]
机构
[1] NYU, Sch Med, Dept Pathol, Inst Canc, New York, NY 10016 USA
[2] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oral Mol Pathol, Tokushima 7708501, Japan
[3] Stowers Inst Med Res, Kansas City, MO 64110 USA
[4] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA
[5] Howard Hughes Med Inst, Bethesda, MD USA
基金
美国国家卫生研究院;
关键词
NORMAL-CELL CYCLE; SEQUENCE-ANALYSIS; R2; PROTEIN; DTTP POOL; DAMAGE; REPLICATION; SUBUNIT; CHECKPOINT; MUTATIONS; KINASE;
D O I
10.1016/j.cell.2012.03.043
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
F-box proteins are the substrate binding subunits of SCF (Skp1-Cul1-F-box protein) ubiquitin ligase complexes. Using affinity purifications and mass spectrometry, we identified RRM2 (the ribonucleotide reductase family member 2) as an interactor of the F-box protein cyclin F. Ribonucleotide reductase (RNR) catalyzes the conversion of ribonucleotides to deoxyribonucleotides (dNTPs), which are necessary for both replicative and repair DNA synthesis. We found that, during G2, following CDK-mediated phosphorylation of Thr33, RRM2 is degraded via SCFcyclin (F) to maintain balanced dNTP pools and genome stability. After DNA damage, cyclin F is downregulated in an ATR-dependent manner to allow accumulation of RRM2. Defective elimination of cyclin F delays DNA repair and sensitizes cells to DNA damage, a phenotype that is reverted by expressing a nondegradable RRM2 mutant. In summary, we have identified a biochemical pathway that controls the abundance of dNTPs and ensures efficient DNA repair in response to genotoxic stress.
引用
收藏
页码:1023 / 1034
页数:12
相关论文
共 27 条
  • [1] Emerging roles of the ribonucleotide reductase M2 in colorectal cancer and ultraviolet-induced DNA damage repair
    Lu, Ai-Guo
    Feng, Hao
    Wang, Pu-Xiong-Zhi
    Han, Ding-Pei
    Chen, Xue-Hua
    Zheng, Min-Hua
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (34) : 4704 - 4713
  • [3] Targeting poor-prognosis subtypes of prostate cancer by inhibition of DNA repair gene ribonucleotide reductase small subunit M2
    Mazzu, Ying Z.
    Armenia, Joshua
    Chakraborty, Goutam
    Yoshikawa, Yuki
    Gerke, Travis A.
    Coggins, Si Ana A.
    Qiu, Xintao
    Atiq, Mohammad
    Stopsack, Konrad H.
    Lee, Gwo-Shu Mary
    Long, Henry W.
    Kim, Baek
    Freedman, Matthew L.
    Pomerantz, Mark M.
    Mucci, Lorelei A.
    Kantoff, Philip W.
    CANCER RESEARCH, 2018, 78 (13)
  • [4] ATR-CHK1-E2F3 signaling transactivates human ribonucleotide reductase small subunit M2 for DNA repair induced by the chemical carcinogen MNNG
    Gong, Chaoju
    Liu, Hong
    Song, Rui
    Zhong, Tingting
    Lou, Meng
    Wang, Tingyang
    Qi, Hongyan
    Shen, Jing
    Zhu, Lijun
    Shao, Jimin
    BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS, 2016, 1859 (04): : 612 - 626
  • [5] Cyclin F-Mediated Degradation of SLBP Limits H2A.X Accumulation and Apoptosis upon Genotoxic Stress in G2
    Dankert, John F.
    Rona, Gergely
    Clijsters, Linda
    Geter, Phillip
    Skaar, Jeffrey R.
    Bermudez-Hernandez, Keria
    Sassani, Elizabeth
    Fenyo, David
    Ueberheide, Beatrix
    Schneider, Robert
    Pagano, Michele
    MOLECULAR CELL, 2016, 64 (03) : 507 - 519
  • [6] Reversal of hydroquinone-mediated suppression of T cell proliferation by transfection of the M2 subunit of ribonucleotide reductase
    Li, Q
    Kasten-Jolly, J
    Yen, Y
    Freed, BM
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 1998, 150 (01) : 154 - 157
  • [7] A Novel Mechanism Driving Poor-Prognosis Prostate Cancer: Overexpression of the DNA Repair Gene, Ribonucleotide Reductase Small Subunit M2 (RRM2)
    Mazzu, Ying Z.
    Armenia, Joshua
    Chakraborty, Goutam
    Yoshikawa, Yuki
    Coggins, Si'Ana A.
    Nandakumar, Subhiksha
    Gerke, Travis A.
    Pomerantz, Mark M.
    Qiu, Xintao
    Zhao, Huiyong
    Atiq, Mohammad
    Khan, Nabeela
    Komura, Kazumasa
    Lee, Gwo-Shu Mary
    Fine, Samson W.
    Bell, Connor
    O'Connor, Edward
    Long, Henry W.
    Freedman, Matthew L.
    Kim, Baek
    Kantoff, Philip W.
    CLINICAL CANCER RESEARCH, 2019, 25 (14) : 4480 - 4492
  • [8] Retrovirally mediated RNA interference targeting the M2 subunit of ribonucleotide reductase: A novel therapeutic strategy in pancreatic cancer
    Duxbury, MS
    Ito, H
    Benoit, E
    Zinner, MJ
    Ashley, SW
    Whang, EE
    SURGERY, 2004, 136 (02) : 261 - 269
  • [9] Repositioning of a cyclin-dependent kinase inhibitor GW8510 as a ribonucleotide reductase M2 inhibitor to treat human colorectal cancer
    Hsieh, Y-Y
    Chou, C-J
    Lo, H-L
    Yang, P-M
    CELL DEATH DISCOVERY, 2016, 2
  • [10] Repositioning of a cyclin-dependent kinase inhibitor GW8510 as a ribonucleotide reductase M2 inhibitor to treat human colorectal cancer
    Y-Y Hsieh
    C-J Chou
    H-L Lo
    P-M Yang
    Cell Death Discovery, 2